Irhythm Technologies Inc (IRTC) Stock Price, Quote & News

Company Profile

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) moni...

Industry: Medical Devices

Sector: Healthcare

Phone: 415 632 5700

Website: www.irhythmtech.com

Address:

699 8th Street, Suite 600, San Francisco, United States

BillionerOfKing May. 5 at 9:42 PM

$IRTC Current Stock Price: $118.11 Contracts to trade: $120.0 IRTC May 15 2026 Call Entry: $2.35 Exit: $3.21 ROI: 37% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday May. 1 at 3:42 PM

$IRTC Share Price: $120.50 Contract Selected: Nov 20, 2026 $140 Calls Buy Zone: $8.84 – $10.92 Target Zone: $14.47 – $17.69 Potential Upside: 55% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

StocktwitsEarnings Apr. 30 at 8:18 PM

$IRTC Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.43 up 55.67% YoY • Reported revenue of $199.39M up 25.66% YoY • iRhythm increased its fiscal year 2026 revenue guidance to a range of $875M to $885M and adjusted EBITDA margin guidance to 12.0% to 13.0%, reflecting continued volume-led growth and operating leverage.

0 · Reply

Estimize Apr. 30 at 3:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +3.67M Revs compared to WS http://www.estimize.com/irtc/fq1-2026?utm_conten

0 · Reply

NorthStarStats Apr. 28 at 12:57 AM

More low scores from the momentum scanner, but some exciting news. These are setups to watch and study, not trade recommendations. $CRMD Score 90 (BREAKOUT WATCH!), $ADM Score 93, $VST Score 73, $MGM Score 70, $IRTC Score 70

0 · Reply

BioTechHealthX Apr. 26 at 6:18 PM

$IRTC iRhythm Technologies (NASDAQ: IRTC) is revolutionizing heart monitoring with AI-powered diagnostics. With strong clinical data and rising adoption, this stock could be a major player in the future of digital healthcare. https://biotechhealthx.com/biotech-news/is-it-a-great-move-to-invest-in-irhythm-technologies-irtc/

0 · Reply

TipRanks Apr. 24 at 10:09 AM

2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On https://www.tipranks.com/news/article/2-under-the-radar-wearable-ai-stocks-analysts-are-bullish-on $AMBQ $IRTC

0 · Reply

BioTechHealthX Apr. 23 at 12:06 AM

$BSX $IRTC $TEM $TDOC $VEEV Looking for the best AI healthcare stocks? These top 5 best medical AI companies are leading the next wave of innovation in diagnostics, telemedicine, and drug development—before Wall Street fully catches on. https://biotechhealthx.com/biotech-news/top-5-best-medical-ai-stocks-that-could-deliver-100-returns/

0 · Reply

OfficialStocktwitsUser Mar. 12 at 11:57 PM

$IRTC RSI: 13.25, MACD: -9.8677 Vol: 12.67, MA20: 135.21, MA50: 152.62 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

jb02345 Mar. 11 at 3:52 PM

$IRTC always goes up after earnings. Accumulate now

0 · Reply

iRhythm Holdings Transcript: Bank of America Global Healthcare Conference 2026

2026-05-04T10:51:11.000Z - 9 days ago

iRhythm price target raised to $157 from $155 at Citi

2026-05-01T15:13:53.000Z - 12 days ago

iRhythm price target raised to $174 from $170 at Truist

2026-05-01T14:39:20.000Z - 12 days ago

iRhythm price target raised to $175 from $166 at Baird

2026-05-01T12:56:35.000Z - 12 days ago

iRhythm price target lowered to $175 from $215 at JPMorgan

2026-05-01T12:32:50.000Z - 12 days ago

iRhythm price target lowered to $185 from $225 at Oppenheimer

2026-05-01T12:17:43.000Z - 12 days ago

iRhythm price target lowered to $160 from $170 at Evercore ISI

2026-05-01T11:41:39.000Z - 12 days ago

iRhythm price target raised to $255 from $254 at Needham

2026-05-01T10:48:25.000Z - 12 days ago

iRhythm price target lowered to $180 from $198 at Canaccord

Apr 30, 2026, 4:30 PM EDT - 13 days ago

iRhythm Holdings Earnings Call Transcript: Q1 2026

2026-04-30T20:15:43.000Z - 13 days ago

iRhythm sees FY26 revenue $875M-$885M, consensus $876.16M

Apr 30, 2026, 4:05 PM EDT - 13 days ago

iRhythm Holdings Announces First Quarter 2026 Financial Results

Apr 28, 2026, 4:05 PM EDT - 15 days ago

iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference

Apr 27, 2026, 8:05 AM EDT - 16 days ago

New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy

Apr 16, 2026, 4:05 PM EDT - 27 days ago

iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026

2026-04-15T12:43:35.000Z - 4 weeks ago

iRhythm price target lowered to $170 from $200 at Truist

2026-04-13T12:02:30.000Z - 4 weeks ago

iRhythm price target lowered to $185 from $215 at BTIG

Apr 9, 2026, 6:44 PM EDT - 4 weeks ago

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

2026-04-07T10:59:33.000Z - 5 weeks ago

iRhythm price target lowered to $155 from $214 at Citi

2026-04-06T12:17:21.000Z - 5 weeks ago

iRhythm price target lowered to $170 from $210 at Evercore ISI

Mar 30, 2026, 8:05 AM EDT - 6 weeks ago

Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform

Mar 12, 2026, 4:30 PM EDT - 2 months ago

iRhythm Holdings Appoints Jason Patten to its Board of Directors

2026-03-11T09:25:40.000Z - 2 months ago

iRhythm price target lowered to $214 from $242 at Citi

2026-02-23T12:47:49.000Z - 2 months ago

iRhythm price target lowered to $200 from $215 at Truist

2026-02-23T11:51:50.000Z - 2 months ago

iRhythm price target lowered to $184 from $211 at Goldman Sachs

2026-02-20T18:25:51.000Z - 2 months ago

iRhythm should be bought on subpoena weakness, says William Blair

Feb 19, 2026, 4:30 PM EST - 2 months ago

iRhythm Holdings Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:05 PM EST - 2 months ago

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results

Feb 5, 2026, 4:30 PM EST - 3 months ago

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Jan 29, 2026, 5:02 PM EST - 3 months ago

HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Jan 15, 2026, 11:22 AM EST - 4 months ago

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 12, 2026, 11:15 AM EST - 4 months ago

iRhythm Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:30 AM EST - 4 months ago

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:30 PM EST - 4 months ago

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 4, 2025, 9:10 AM EST - 5 months ago

iRhythm Holdings Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 3, 2025, 1:00 PM EST - 5 months ago

iRhythm Holdings Transcript: Citi Annual Global Healthcare Conference 2025

Nov 20, 2025, 5:00 AM EST - 6 months ago

iRhythm Holdings Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 9:20 AM EST - 6 months ago

iRhythm Holdings Transcript: Wolfe Research Healthcare Conference 2025

Nov 11, 2025, 8:05 AM EST - 6 months ago

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

Nov 5, 2025, 1:38 PM EST - 6 months ago

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

Nov 4, 2025, 4:30 PM EST - 6 months ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

Oct 30, 2025, 4:30 PM EDT - 6 months ago

iRhythm Holdings Earnings Call Transcript: Q3 2025

Oct 30, 2025, 4:05 PM EDT - 6 months ago

iRhythm Technologies Announces Third Quarter 2025 Financial Results

Oct 16, 2025, 4:30 PM EDT - 7 months ago

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

Sep 18, 2025, 1:30 PM EDT - 8 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

Sep 10, 2025, 12:50 PM EDT - 8 months ago

iRhythm Holdings Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 2:35 PM EDT - 8 months ago

iRhythm Holdings Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 12:45 PM EDT - 9 months ago

iRhythm Holdings Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 29, 2025, 7:00 AM EDT - 9 months ago

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

Aug 18, 2025, 8:05 AM EDT - 9 months ago

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

Jul 31, 2025, 4:30 PM EDT - 10 months ago

iRhythm Holdings Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:05 PM EDT - 10 months ago

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Jul 25, 2025, 6:35 PM EDT - 10 months ago

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 17, 2025, 4:30 PM EDT - 10 months ago

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

Jul 11, 2025, 10:12 PM EDT - 10 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 7, 2025, 8:30 AM EDT - 11 months ago

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Jun 23, 2025, 8:30 AM EDT - 11 months ago

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jun 17, 2025, 1:40 PM EDT - 11 months ago

iRhythm Holdings Transcript: 2025 Truist Securities MedTech Conference

Jun 10, 2025, 2:40 PM EDT - 1 year ago

iRhythm Holdings Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 4, 2025, 3:00 PM EDT - 1 year ago

iRhythm Holdings Transcript: 45th Annual William Blair Growth Stock Conference

May 13, 2025, 6:40 PM EDT - 1 year ago

iRhythm Holdings Transcript: Bank of America 2025 Healthcare Conference

May 1, 2025, 4:30 PM EDT - 1 year ago

iRhythm Holdings Earnings Call Transcript: Q1 2025

May 1, 2025, 4:10 PM EDT - 1 year ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

Apr 29, 2025, 6:05 PM EDT - 1 year ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

Apr 28, 2025, 8:05 AM EDT - 1 year ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Apr 17, 2025, 4:30 PM EDT - 1 year ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 16, 2025, 8:35 AM EDT - 1 year ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

Mar 31, 2025, 8:05 AM EDT - 1 year ago

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Feb 20, 2025, 4:30 PM EST - 1 year ago

iRhythm Holdings Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:05 PM EST - 1 year ago

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 6, 2025, 4:05 PM EST - 1 year ago

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

BillionerOfKing May. 5 at 9:42 PM

0 · Reply

SuperGreenToday May. 1 at 3:42 PM

0 · Reply

StocktwitsEarnings Apr. 30 at 8:18 PM

0 · Reply

Estimize Apr. 30 at 3:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +3.67M Revs compared to WS http://www.estimize.com/irtc/fq1-2026?utm_conten

0 · Reply

NorthStarStats Apr. 28 at 12:57 AM

0 · Reply

BioTechHealthX Apr. 26 at 6:18 PM

0 · Reply

TipRanks Apr. 24 at 10:09 AM

2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On https://www.tipranks.com/news/article/2-under-the-radar-wearable-ai-stocks-analysts-are-bullish-on $AMBQ $IRTC

0 · Reply

BioTechHealthX Apr. 23 at 12:06 AM

0 · Reply

OfficialStocktwitsUser Mar. 12 at 11:57 PM

0 · Reply

jb02345 Mar. 11 at 3:52 PM

$IRTC always goes up after earnings. Accumulate now

0 · Reply

JR679 Feb. 23 at 6:12 PM

$IRTC

0 · Reply

JR679 Feb. 20 at 1:59 PM

$IRTC

0 · Reply

StocktwitsEarnings Feb. 19 at 9:22 PM

$IRTC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.17 up 525.00% YoY • Reported revenue of $208.89M up 27.12% YoY • For the full year 2026, iRhythm expects revenue of $870M to $880M and adjusted EBITDA margin of 11.5% to 12.5%, reflecting continued volume-led growth and gross margin expansion.

0 · Reply

Estimize Feb. 19 at 4:00 PM

$IRTC reports after the close, Estimize Consensus +0.03 EPS and +2.40M Revs compared to WS http://www.estimize.com/irtc/fq4-2025?utm_conten

0 · Reply

OfficialStocktwitsUser Feb. 13 at 11:07 AM

$IRTC RSI: 38.21, MACD: -5.8198 Vol: 7.55, MA20: 156.55, MA50: 167.87 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Feb. 12 at 10:14 AM

$IRTC Share Price: $152.14 Contract Selected: Aug 21, 2026 $150 Calls Buy Zone: $18.02 – $22.25 Target Zone: $34.15 – $41.74 Potential Upside: 79% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Feb. 2 at 4:13 PM

$IRTC Share Price: $157.71 Contract Selected: Aug 21, 2026 $170 Calls Buy Zone: $14.96 – $18.48 Target Zone: $25.71 – $31.43 Potential Upside: 62% ROI Time to Expiration: 199 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Jan. 30 at 3:44 PM

$IRTC Share Price: $151.19 Contract Selected: Aug 21, 2026 $145 Calls Buy Zone: $19.80 – $24.47 Target Zone: $34.70 – $42.41 Potential Upside: 65% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Leondog1992 Jan. 30 at 3:23 PM

$APGE $IRTC $MDB $HL $IESC

0 · Reply

Leondog1992 Jan. 29 at 7:04 PM

$FROG $GH $GMED $IRTC $RKT Just remember money and this life is only Temporary. Jesus is king

1 · Reply

Leondog1992 Jan. 29 at 4:43 PM

$FROG $RKT $GH $IRTC $GMED

0 · Reply

Leondog1992 Jan. 29 at 2:46 PM

$IRTC

0 · Reply

Market Cap	5.78B
Revenue (ttm)	591.84M
Net Income (ttm)	-113.29M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.14%
Debt to Equity Ratio	0.00

Volume	1,454,100
Avg Vol	495,702
Day's Range	N/A - N/A
Shares Out	32.22M
Stochastic %K	35%
Beta	1.12
Analysts	Strong Sell
Price Target	$219.64